Adherence with colorectal cancer screening guidelines: A review

Preventive Medicine

Volumn 38, Issue 5, 2004, Pages 536-550

  Subramanian, Sujha ^a   Klosterman, Michelle ^a   Amonkar, Mayur M ^b   Hunt, Timothy L ^b  

^a RTI INTERNATIONAL   (United States)

^b PFIZER INC   (United States)

Author keywords

Adherence; Colonoscopy; Colorectal cancer; FOBT; Screening; Sigmoidoscopy

Indexed keywords

CANCER MORTALITY; CANCER RISK; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; COMPUTED TOMOGRAPHIC COLONOGRAPHY; CORRELATION ANALYSIS; FATALITY; HUMAN; MEDLINE; OCCULT BLOOD TEST; PATIENT COMPLIANCE; PHYSICIAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSYCINFO; REVIEW; SCREENING TEST; SIGMOIDOSCOPY; UNITED STATES;

EID: 1842580506     PISSN: 00917435     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ypmed.2003.12.011     Document Type: Article

References (138)

1. Greenlee R.T., Hill_Harmon M.B., Murray T., Thun M. Cancer statistics. CA Cancer J. Clin. 51:2001;15-36.
2. Smith R.A., von Eschenbach A.C., Wender R., Levin B., Byers T., Rothenberger D.et al. American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers. Also: update 2001 - Testing for early lung cancer detection. CA Cancer J. Clin. 51:2001;38-75.
3. Rex D.K., Johnson D.A., Lieberman D.A., Burt R.W., Sonnenberg A. Colorectal cancer prevention: screening recommendations of the American College of Gastroenterology. American College of Gastroenterology. Am. J. Gastroenterol. 95:2000;868-877.
4. Winawer S.J., Fletcher R.H., Miller L., Godlee F., Stolar M.H., Mulrow C.D.et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology. 112:1997;594-642.
5. Guide to Clinical Preventive Services. Report of the US Prevention Services Task Force. Washington, DC. Department of Health and Human Services; 1995.
6. Healthy People 2010. Washington, DC. US Department of Health and Human Services; 2000.
7. Seeff L., Nadel M., Blackman D., Pollack L.A. Colorectal cancer test use among persons aged 50 years and older - United States, 2001. MMWR. 52:2003;193-196.
8. Vijan S., Hwang E.W., Hofer T.P., Hayward R.A. Which colon cancer screening test? A comparison of costs, effectiveness, and compliance. Am. J. Med. 111:2001;593-601.
9. Crott R. The cost-effectiveness of screening for colorectal cancer. Expert Rev. Pharmacoeconomics Outcomes Res. 1:2001;157-166.
10. Pignone M., Saha S., Hoerger T., Mandelblatt J. Cost-effectiveness analyses of colorectal cancer screening: a systematic review for the U.S. Preventive Services Task Force. Ann. Intern. Med. 137:2002;96-104.
11. Lieberman D.A. Cost-effectiveness model for colon cancer screening. Gastroenterology. 109:1995;1781-1790.
12. Frazier A.L., Colditz G.A., Fuchs C.S., Kuntz K.M. JAMA. 284(15):2000;1954-1961.
13. Vernon S.W. Participation in colorectal cancer screening: a review. J. Natl. Cancer Inst. 89:1997;1406-1422.
14. Blalock S.J., DeVellis B.M., Sandler R.S. Participation in fecal occult blood screening: a critical review. Prev. Med. 16:1987;9-18.
15. Lieberman D.A., Weiss D.G., Bond J.H., Ahnen D.J., Garewal H., Chejfec G. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N. Engl. J. Med. 343:2000;162-168.
16. Nelson D.B., McQuaid K.R., Bond J.H., Lieberman D.A., Weiss D.G., Johnston T.K. Procedural success and complications of large-scale screening colonoscopy. Gastrointest. Endosc. 55:2002;307-314.
17. Borum M.L. Colorectal cancer surveillance in African-American and white patients at an urban university medical center. J. Natl. Med. Assoc. 91:1999;505-508.
18. Ellerbeck E.F., Engelman K.K., Gladden J., Mosier M.C., Raju G.S., Ahluwalia J.S. Direct observation of counseling on colorectal cancer in rural primary care practices. J. Gen. Intern. Med. 16:2001;697-700.
19. Bergner M., Allison C.J., Diehr P., Ford L.G., Feigl P. Early detection and control of cancer in clinical practice. Arch. Intern. Med. 150:1990;431-436.
20. Fox S.A., Murata P.J., Stein J.A. The impact of physician compliance on screening mammography for older women. Arch. Intern. Med. 151:1991;50-56.
21. Caplan L.S., Wells B.L., Haynes S. Breast cancer screening among older racial/ethnic minorities and whites: barriers to early detection. J. Gerontol. 47:1992;. (Spec Iss):101-10.
22. Mandelblatt J., Traxler M., Lakin P., Kanetsky P., Kao R. Mammography and Papanicolaou smear use by elderly poor black women. The Harlem Study Team. J. Am. Geriatr. Soc. 40:1992;1001-1007.
23. Manne S., Markowitz A., Winawer S., Meropol N.J., Haller D., Rakowski W.et al. Correlates of colorectal cancer screening compliance and stage of adoption among siblings of individuals with early onset colorectal cancer. Health Psychol. 21:2002;3-15.
24. Lewis S.F., Jensen N.M. Screening sigmoidoscopy. Factors associated with utilization. J. Gen. Intern. Med. 11:1996;542-544.
25. Holt W.S. Jr. Factors affecting compliance with screening sigmoidoscopy. J. Fam. Pract. 32:1991;585-589.
26. Kelly R.B., Shank J.C. Adherence to screening flexible sigmoidoscopy in asymptomatic patients. Med. Care. 30:1992;1029-1042.
27. Schroy P.C. III, Geller A.C., Crosier W.M., Page M., Sutherland L., Holm L.J.et al. Utilization of colorectal cancer screening tests: a 1997 survey of Massachusetts internists. Prev. Med. 33:2001;381-391.
28. Hawley S.T., Foxhall L., Vernon S.W., Levin B., Young J.E. Colorectal cancer screening by primary care physicians in Texas: a rural-urban comparison. J. Cancer Educ. 16:2001;199-204.
29. Zapka J.G., Puleo E., Vickers-Lahti M., Luckmann R. Healthcare system factors and colorectal cancer screening. Am. J. Prev. Med. 23:2002;28-35.
30. O'Malley A.S., Forrest C.B., Mandelblatt J. Adherence of low-income women to cancer screening recommendations. J. Gen. Intern. Med. 17:2002;144-154.
31. Hsia J., Kemper E., Kiefe C., Zapka J., Sofaer S., Pettinger M.et al. The importance of health insurance as a determinant of cancer screening: evidence from the Women's Health Initiative. Prev. Med. 31:2000;261-270.
32. Lemon S., Zapka J., Puleo E., Luckmann R., Chasan-Taber L. Colorectal cancer screening participation: comparisons with mammography and prostate-specific antigen screening. Am. J. Public Health. 91:2001;1264-1272.
33. Mandelson M.T., Curry S.J., Anderson L.A., Nadel M.R., Lee N.C., Rutter C.M.et al. Colorectal cancer screening participation by older women. Am. J. Prev. Med. 19:2000;149-154.
34. Vernon S.W. Risk perception and risk communication for cancer screening behaviors: a review. J. Natl. Cancer Inst. Monographs. 1999;101-119.
35. Zack D.L., DiBaise J.K., Quigley E.M., Roy H.K. Colorectal cancer screening compliance by medicine residents: perceived and actual. Am. J. Gastroenterol. 96:2001;3004-3008.
36. Cooper G.S., Yuan Z., Veri L., Rimm A.A., Stange K.C. Colorectal carcinoma screening attitudes and practices among primary care physicians in counties at extremes of either high or low cancer case-fatality. Cancer. 86:1999;1669-1674.
37. Wender R.C. Barriers to screening for colorectal cancer. Gastrointest. Endosc. Clin. N. Am. 12:2002;145-170.
38. Wolf R.L., Zybert P., Brouse C.H., Neugut A.I., Shea S., Gibson G.et al. Knowledge, beliefs, and barriers relevant to colorectal cancer screening in an urban population: a pilot study. Fam. Commun. Health. 24:2001;34-47.
39. Sharma V.K., Vasudeva R., Howden C.W. Colorectal cancer screening and surveillance practices by primary care physicians: results of a national survey. Am. J. Gastroenterol. 95:2000;1551-1556.
40. Erban S., Zapka J., Puleo E., Vickers-Lahti M. Colorectal cancer screening in Massachusetts: measuring compliance with current guidelines. Eff. Clin. Pract. 4:2001;10-17.
41. Schoen R.E., Weissfeld J.L., Trauth J.M., Ling B.S., Hayran M. A population-based, community estimate of total colon examination: the impact on compliance with screening for colorectal cancer. Am. J. Gastroenterol. 97:2002;446-451.
42. Tilley B.C., Vernon S.W., Glanz K., Myers R., Sanders K., Lu M.et al. Worksite cancer screening and nutrition intervention for high-risk auto workers: design and baseline findings of the Next Step Trial. Prev. Med. 26:1997;227-235.
43. Laville E.A., Vernon S.W., Jackson G.L., Hughes J.I. Comparison of participants and nonparticipants in a work site cancer awareness and screening program. J. Occup. Med. 31:1989;221-232.
44. Bernstein A.B., Thompson G.B., Harlan L.C. Differences in rates of cancer screening by usual source of medical care. Data from the 1987 National Health Interview Survey. Med. Care. 29:1991;196-209.
45. Brown M.L., Potosky A.L., Thompson G.B., Kessler L.G. The knowledge and use of screening tests for colorectal and prostate cancer: data from the 1987 National Health Interview Survey. Prev. Med. 19:1990;562-574.
46. Jepson C., Kessler L.G., Portnoy B., Gibbs T. Black-white differences in cancer prevention knowledge and behavior. Am. J. Public Health. 81:1991;501-504.
47. Powe B.D. Fatalism among elderly African Americans. Effects on colorectal cancer screening. Cancer Nurs. 18:1995;385-392.
48. Thrasher J.F., Cummings K.M., Michalek A.M., Mahoney M.C., Moysich K.B., Pillittere D.M. Colorectal cancer screening among individuals with and without a family history. J. Public Health Manag. Pract. 8:2002;1-9.
49. Breen N., Wagener D.K., Brown M.L., Davis W.W., Ballard-Barbash R. Progress in cancer screening over a decade: results of cancer screening from the 1987, 1992, and 1998 National Health Interview Surveys. J. Natl. Cancer Inst. 93:2001;1704-1713.
50. McGarrity T.J., Long P.A., Peiffer L.P. Results of a repeat television-advertised mass screening program for colorectal cancer using fecal occult blood tests. Am. J. Gastroenterol. 85:1990;266-270.
51. Morris J.B., Stellato T.A., Guy B.B., Gordon N.H., Berger N.A. A critical analysis of the largest reported mass fecal occult blood screening program in the United States. Am. J. Surg. 161:1991;101-105.
52. Petrelli N.J., Palmer M., Michalek A., Herrera L., Mink I., Bersani G.et al. Massive screening for colorectal cancer. A single institution's public commitment. Arch. Surg. 125:1990;1049-1051.
53. Gordon D., Doty G.L. Issues impacting on acceptance and compliance in a community based colorectal screening program. Prog. Clin. Biol. Res. 248:1987;53-65.
54. Cummings K.M., Michalek A., Mettlin C., Mittelman A. Screening for colorectal cancer using the Hemoccult II stool guaiac slide test. Cancer. 53:1984;2201-2205.
55. Miller M.P., Stanley T.V. Results of a mass screening program for colorectal cancer. Arch. Surg. 123:1988;63-65.
56. Michalek A.M., Cummings K.M., Gamble D. The use of a cancer registry in a mass screening program for colorectal cancer. Cancer Detec. Prev. 11:1988;353-357.
57. Winchester D.P., Shull J.H., Scanlon E.F., Murrell J.V., Smeltzer C., Vrba P.et al. A mass screening program for colorectal cancer using chemical testing for occult blood in the stool. Cancer. 45:1980;2955-2958.
58. Winchester D.P., Sylvester J., Maher M.L. Risks and benefits of mass screening for colorectal neoplasia with the stool guaiac test. CA Cancer J. Clin. 33:1983;333-343.
59. Chang F.C., Jackson T.M., Jackson C.R. Hemoccult screening for colorectal cancer. Am. J. Surg. 156:1988;457-459.
60. Khubchandani I.T., Karamchandani M.C., Kleckner F.S., Sheets J.A., Stasik J.J., Rosen L.et al. Mass screening for colorectal cancer. Dis. Colon Rectum. 32:1989;754-758.
61. Bloch S., Ashwanden P., Neugut A.I., Field M., Rubin M., Apfelbaum T.et al. Utilizing television to promote a community colon cancer screening program. Prog. Clin. Biol. Res. 339:1990;311-323.
62. Myers R.E., Trock B.J., Lerman C., Wolf T., Ross E., Engstrom P.F. Adherence to colorectal cancer screening in an HMO population. Prev. Med. 19:1990;502-514.
63. Myers R.E., Ross E.A., Wolf T.A., Balshem A., Jepson C., Miller L. Behavioral interventions to increase adherence in colorectal cancer screening. Med. Care. 29:1991;1039-1050.
64. Myers R.E., Ross E., Jepson C., Wolf T., Balshem A., Millner L.et al. Modeling adherence to colorectal cancer screening. Prev. Med. 23:1994;142-151.
65. Mandel J.S., Bond J.H., Church T.R., Snover D.C., Bradley G.M., Schuman L.M.et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N. Engl. J. Med. 328:1993;1365-1371.
66. Thomas W., White C.M., Mah J., Geisser M.S., Church T.R., Mandel J.S. Longitudinal compliance with annual screening for fecal occult blood. Minnesota Colon Cancer Control Study. Am. J. Epidemiol. 142:1995;176-182.
67. Park S.I., Saxe J.C., Weesner R.E. Does use of the coloscreen self-test improve patient compliance with fecal occult blood screening? Am. J. Gastroenterol. 88:1993;1391-1394.
68. Friedman L.C., Everett T.E., Peterson L., Ogbonnaya K.I., Mendizabal V. Compliance with fecal occult blood test screening among low-income medical outpatients: a randomized controlled trial using a videotaped intervention. J. Cancer Educ. 16:2001;85-88.
69. Thompson R.S., Michnich M.E., Gray J., Friedlander L., Gilson B. Maximizing compliance with hemoccult screening for colon cancer in clinical practice. Med. Care. 24:1986;904-914.
70. Thompson N.J., Boyko E.J., Dominitz J.A., Belcher D.W., Chesebro B.B., Stephens L.M.et al. A randomized controlled trial of a clinic-based support staff intervention to increase the rate of fecal occult blood test ordering. Prev. Med. 30:2000;244-251.
71. Bejes C., Marvel M.K. Attempting the improbable: offering colorectal cancer screening to all appropriate patients. Fam. Pract. Res. J. 12:1992;83-90.
72. Burack R.C., Liang J. The early detection of cancer in the primary-care setting: factors associated with the acceptance and completion of recommended procedures. Prev. Med. 16:1987;739-751.
73. Morrow G.R., Way J., Hoagland A.C., Cooper R. Patient compliance with self-directed Hemoccult testing. Prev. Med. 11:1982;512-520.
74. Spector M.H., Applegate W.B., Olmstead S.J., DiVasto P.V., Skipper B. Assessment of attitudes toward mass screening for colorectal cancer and polyps. Prev. Med. 10:1981;105-109.
75. Chait M., Herbert E., Guthrie M.et al. The Memorial Sloan-Kettering Cancer Center-Strang Clinic Program: a progress report. Front. Gastrointest. Res. 10:1986;102-111.
76. Lieberman D.A., Weiss D.G. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon. N. Engl. J. Med. 345:2001;555-560.
77. Struewing J.P., Pape D.M., Snow D.A. Improving colorectal cancer screening in a medical residents' primary care clinic. Am. J. Prev. Med. 7:1991;75-81.
78. Pignone M., Harris R., Kinsinger L. Videotape-based decision aid for colon cancer screening. A randomized, controlled trial. Ann. Intern. Med. 133:2000;761-769.
79. Winawer S.J., Flehinger B.J., Schottenfeld D., Miller D.G. Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy. J. Natl. Cancer Inst. 85:1993;1311-1318.
80. McCarthy B.D., Moskowitz M.A. Screening flexible sigmoidoscopy: patient attitudes and compliance. J. Gen. Intern. Med. 8:1993;120-125.
81. Hahn D.L., Berger M.G. Implementation of a systematic health maintenance protocol in a private practice. J. Fam. Pract. 31:1990;492-502.
82. Richardson J.L., Danley K., Mondrus G.T., Deapen D., Mack T. Adherence to screening examinations for colorectal cancer after diagnosis in a first-degree relative. Prev. Med. 24:1995;166-170.
83. Sandler R.S., DeVellis B.M., Blalock S.J., Holland K.L. Participation of high-risk subjects in colon cancer screening. Cancer. 63:1989;2211-2215.
84. Blalock S.J., DeVellis B.M., Afifi R.A., Sandler R.S. Risk perceptions and participation in colorectal cancer screening. Health Psychol. 9:1990;792-806.
85. Codori A.M., Petersen G.M., Miglioretti D.L., Boyd P. Health beliefs and endoscopic screening for colorectal cancer: potential for cancer prevention. Prev. Med. 33:2001;128-136.
86. Rawl S.M., Menon U., Champion V.L., Foster J.L., Skinner C.S. Colorectal cancer screening beliefs. Focus groups with first-degree relatives. Cancer Pract. 8:2000;32-37.
87. Tilley B.C., Vernon S.W., Myers R., Glanz K., Lu M., Hirst K.et al. The Next Step Trial: impact of a worksite colorectal cancer screening promotion program. Prev. Med. 28:1999;276-283.
88. Vernon S.W., Acquavella J.F., Yarborough C.M., Hughes J.I., Thar W.E. Reasons for participation and nonparticipation in a colorectal cancer screening program for a cohort of high risk polypropylene workers. J. Occup. Med. 32:1990;46-51.
89. Vernon S.W., Myers R.E., Tilley B.C., Li S. Factors associated with perceived risk in automotive employees at increased risk of colorectal cancer. Cancer Epidemiol. Biomark. Prev. 10:2001;35-43.
90. Neale A.V., Demers R.Y., Herman S. Compliance with colorectal cancer screening in a high-risk occupational group. J. Occup. Med. 31:1989;1007-1012.
91. Ruffin M.T., Gorenflo D.W., Woodman B. Predictors of screening for breast, cervical, colorectal, and prostatic cancer among community-based primary care practices. J. Am. Board Fam. Pract. 13:2000;1-10.
92. Polednak A.P. Knowledge of colorectal cancer and use of screening tests in persons 40-74 years of age. Prev. Med. 19:1990;213-226.
93. Potosky A.L., Breen N., Graubard B.I., Parsons P.E. The association between health care coverage and the use of cancer screening tests. Results from the 1992 National Health Interview Survey. Med. Care. 36:1998;257-270.
94. Beeker C., Kraft J.M., Southwell B.G., Jorgensen C.M. Colorectal cancer screening in older men and women: qualitative research findings and implications for intervention. J. Commun. Health. 25:2000;263-278.
95. Price J.H. Perceptions of colorectal cancer in a socioeconomically disadvantaged population. J. Commun. Health. 18:1993;347-362.
96. Bostick R.M., Sprafka J.M., Virnig B.A., Potter J.D. Knowledge, attitudes, and personal practices regarding prevention and early detection of cancer. Prev. Med. 22:1993;65-85.
97. Weitzman E.R., Zapka J., Estabrook B., Goins K.V. Risk and reluctance: understanding impediments to colorectal cancer screening. Prev. Med. 32:2001;502-513.
98. Maxwell A.E., Bastani R., Warda U.S. Demographic predictors of cancer screening among Filipino and Korean immigrants in the United States. Am. J. Prev. Med. 18:2000;62-68.
99. Mandel I.G., Franks P., Dickinson J.C. Screening guidelines in a family medicine program: a five-year experience. J. Fam. Pract. 14:1982;901-907.
100. Myers R.E., Balshem A.M., Wolf T.A., Ross E.A., Millner L. Adherence to continuous screening for colorectal neoplasia. Med. Care. 31:1993;508-519.
101. Weissfeld J.L., Ling B.S., Schoen R.E., Bresalier R.S., Riley T., Prorok P.C. Adherence to repeat screening flexible sigmoidoscopy in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. Cancer. 94:2002;2569-2576.
102. DiPalma A.M., Barnes S.E., DiPalma J.A. Patient participation in colon cancer screening programs. South. Med. J. 91:1998;342-344.
103. Schoen R.E., Weissfeld J.L., Bowen N.J., Switzer G., Baum A. Patient satisfaction with screening flexible sigmoidoscopy. Arch. Intern. Med. 160:2000;1790-1796.
104. Leard L.E., Savides T.J., Ganiats T.G. Patient preferences for colorectal cancer screening. J. Fam. Pract. 45:1997;205-208.
105. Ling B.S., Moskowitz M.A., Wachs D., Pearson B., Schroy P.C. Attitudes toward colorectal cancer screening tests. J. Gen. Intern. Med. 16:2001;822-830.
106. Pignone M., Bucholtz D., Harris R. Patient preferences for colon cancer screening. J. Gen. Intern. Med. 14:1999;432-437.
107. Lewis J.D., Asch D.A., Ginsberg G.G., Hoops T.C., Kochman M.L., Bilker W.B.et al. Primary care physicians' decisions to perform flexible sigmoidoscopy. J. Gen. Intern. Med. 14:1999;297-302.
108. Herman C.J., Hoffman R.M., Altobelli K.K. Variation in recommendations for cancer screening among primary care physicians in New Mexico. J. Commun. Health. 24:1999;253-267.
109. Schroy P.C., Heeren T., Bliss C.M., Pincus J., Wilson S., Prout M. Implementation of on-site screening sigmoidoscopy positively influences utilization by primary care providers. Gastroenterology. 117:1999;304-311.
110. Hawley S.T., Levin B., Vernon S.W. Colorectal cancer screening by primary care physicians in two medical care organizations. Cancer Detec. Prev. 25:2001;309-318.
111. Schoen R.E., Weissfeld J.L., Kuller L.H. Sigmoidoscopy use among primary care physicians. Prev. Med. 24:1995;249-254.
112. Clasen C.M., Vernon S.W., Mullen P.D., Jackson G.L. A survey of physician beliefs and self-reported practices concerning screening for early detection of cancer. Soc. Sci. Med. 39:1994;841-849.
113. Lewis J.D., Ginsberg G.G., Hoops T.C., Kochman M.L., Bilker W.B., Strom B.L. Flexible sigmoidoscopy training and its impact on colorectal cancer screening by primary care physicians. Arch. Fam. Med. 9:2000;420-425.
114. Cooper G.S., Fortinsky R.H., Hapke R., Landefeld C.S. Factors associated with the use of flexible sigmoidoscopy as a screening test for the detection of colorectal carcinoma by primary care physicians. Cancer. 82:1998;1476-1481.
115. Cummings K.M., Jaen C.R., Funch D.P. Family physicians' beliefs about screening for colorectal cancer using the stool guaiac slide test. Public Health Rep. 99:1984;307-312.
116. Cooper G.S., Fortinsky R.H., Hapke R., Landefeld C.S. Primary care physician recommendations for colorectal cancer screening. Patient and practitioner factors. Arch. Intern. Med. 157:1997;1946-1950.
117. Lewis J.D., Asch D.A. Barriers to office-based screening sigmoidoscopy: does reimbursement cover costs? Ann. Intern. Med. 130:1999;525-530.
118. Sharma V.K., Corder F.A., Fancher J., Howden C.W. Survey of the opinions, knowledge, and practices of gastroenterologists regarding colorectal cancer screening and use of the fecal occult blood test. Am. J. Gastroenterol. 95:2000;3629-3632.
119. Czaja R., McFall S.L., Warnecke R.B., Ford L., Kaluzny A.D. Preferences of community physicians for cancer screening guidelines. Ann. Intern. Med. 120:1994;602-608.
120. Rodney W.M., Beaber R.J., Johnson R., Quan M. Physician compliance with colorectal cancer screening (1978-1983): the impact of flexible sigmoidoscopy. J. Fam. Pract. 20:1985;265-269.
121. Selby J.V., Friedman G.D., Quesenberry C.P. Jr., Weiss N.S. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N. Engl. J. Med. 326:1992;653-657.
122. Winawer S.J., Zauber A.G., Ho M.N., O'Brien M.J., Gottlieb L.S., Sternberg S.S.et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N. Engl. J. Med. 329:1993;1977-1981.
123. Bond J.H. Screening guidelines for colorectal cancer. Am. J. Med. 106:1999;7S-10S.
124. Leard L.E., Savides T.J., Ganiats T.G. Patient preferences for colorectal cancer screening. J. Fam. Pract. 45(3):1997;205-208.
125. Vernon S.W., Acquavella J.F., Douglass T.S., Hughes J.I. Factors associated with participation in an occupational program for colorectal cancer screening. J. Occup. Med. 31:1989;458-463.
126. Lewis R.J., Lerman S.E., Schnatter A.R., Hughes J.I., Vernon S.W. Colorectal polyp incidence among polypropylene manufacturing workers. J. Occup. Med. 36:1994;174-181.
127. Steine S. Which hurts the most? A comparison of pain rating during double-contrast barium enema examination and colonoscopy. Radiology. 191:1994;99-101.
128. Dominitz J.A., Provenzale D. Patient preferences and quality of life associated with colorectal cancer screening. Am. J. Gastroenterol. 92:1997;2171-2178.
129. Bond J.H. Colorectal cancer screening. Curr. Opin. Oncol. 10:1998;461-466.
130. Angtuaco T.L., Banaad-Omiotek G.D., Howden C.W. Differing attitudes toward virtual and conventional colonoscopy for colorectal cancer screening: surveys among primary care physicians and potential patients. Am. J. Gastroenterol. 96:2001;887-893.
131. Borum M.L. Medical residents' colorectal cancer screening may be dependent on ambulatory care education. Dig. Dis. Sci. 42:1997;1176-1178.
132. Weinrich S.P., Weinrich M.C., Stromborg M.F., Boyd M.D., Weiss H.L. Using elderly educators to increase colorectal cancer screening. Gerontologist. 33:1993;491-496.
133. Madlon-Kay D.J. Improving the periodic health examination: use of a screening flow chart for patients and physicians. J. Fam. Pract. 25:1987;470-473.
134. Anderson L.M., May D.S. Has the use of cervical, breast, and colorectal cancer screening increased in the United States? Am. J. Public Health. 85:1995;840-842.
135. Community intervention trail for smoking cessaton (COMMIT): II Changes in adult cigarette smoking prevalence. Am. J. Public Health. 85:1995;193-200.
136. Fortmann S.P., Taylor C.B., Flora J.A., Jatulis D.C. Changes in adult cigarette smoking prevalence after 5 years of community health education: the Stanford Five-City Project. Am. J. Epidemiol. 137:1993;82-96.
137. Susser M. The tribulations of trials-interventions in communities. Am. J. Public Health. 85:1995;159-160. [editorial].
138. Montano D.E., Phillips W.R. Cancer screening by primary care physicians: a comparison of rates obtained from physician self-report, patient survey, and chart audit. Am. J. Public Health. 85:1995;795-800.